UniProt ID | ZNF99_HUMAN | |
---|---|---|
UniProt AC | A8MXY4 | |
Protein Name | Zinc finger protein 99 | |
Gene Name | ZNF99 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 864 | |
Subcellular Localization | Nucleus . | |
Protein Description | May be involved in transcriptional regulation.. | |
Protein Sequence | MGSLTFWDVTIEFALEEWQCLDMAQQNLYRNVMLENYRNLVFLGIAVSKLDLITCLKQGKEPWNMKRHEMVTKPPVISSHFTQDFWPDQSIKDSFQEIILRTYARCGHKNLRLRKDCESVNEGKMHEEAYNKLNQCWTTTQGKIFQCNKYVKVFHKYSNSNRYKIRHTKKKTFKCMKCSKSFFMLSHLIQHKRIHTRENIYKCEERGKAFKWFSTLIKHKIIHTEDKPYKYKKCGKAFNISSMFTKCKIIHTGKKPCKCEECGKVFNNSSTLMKHKIIHTGKKPYKCEECGKAFKQSSHLTRHKAIHTGEKPYKCEECGKAFNHFSALRKHQIIHTGKKPYKCEECGKAFSQSSTLRKHEIIHTEEKPYKYEECGKAFSNLSALRKHEIIHTGQKPYKCEECGKAFKWSSKLTVHKVIHTAEKPCKCEECGKAFKRFSALRKHKIIHTGKQPYKCEECSKAFSNFSALRKHEIIHTGEKPYKCEECGKAFKWSSKLTVHKVIHMEEKPCKCEECGKAFKHFSALRKHKIIHTGKKPYKCEECGKAFNNSSTLMKHKIIHTGKKPYKCEECGKAFKQSSHLTRHKAIHTGEKPYKCEECGKAFNHFSALRKHQIIHTGKKPYKCEECGKAFSQSSTLRKHEIIHTGEKPYKCEECGKAFKWSSHLTRHKVIHTEEKPYKCEECGKAFNHFSALRKHKIIHTGKKPYKCEECGKAFSQSSTLRKHEIIHTGEKPYKCEECGKAFKWSSKLTVHKVIHTAEKPCKCEECGKAFKHFSALRKHKIIHTGKKPYKCEECGKAFNNSSTLRKHEIIHTGEKSYKCEECGKAFQWSSKLTLHKVIHMERNPANVKNVAKLLNISQPLENMR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
149 | Ubiquitination | GKIFQCNKYVKVFHK CCEEECCCEEEEEEE | 41.60 | - | |
152 | Ubiquitination | FQCNKYVKVFHKYSN EECCCEEEEEEECCC | 49.76 | - | |
157 | Phosphorylation | YVKVFHKYSNSNRYK EEEEEEECCCCCCEE | 3.20 | 25003641 | |
160 | Phosphorylation | VFHKYSNSNRYKIRH EEEECCCCCCEEEEE | 7.82 | 25003641 | |
163 | Phosphorylation | KYSNSNRYKIRHTKK ECCCCCCEEEEECCC | 23.96 | 25003641 | |
164 | Acetylation | YSNSNRYKIRHTKKK CCCCCCEEEEECCCC | 30.45 | 18524793 | |
170 | Acetylation | YKIRHTKKKTFKCMK EEEEECCCCCEEECC | 60.07 | 18524799 | |
170 | Ubiquitination | YKIRHTKKKTFKCMK EEEEECCCCCEEECC | 60.07 | - | |
201 | Phosphorylation | IHTRENIYKCEERGK CCCCCCHHCHHHHHH | 63.41 | - | |
269 | Phosphorylation | CGKVFNNSSTLMKHK CCCCCCCCHHHHEEE | 46.83 | 22798277 | |
270 | Phosphorylation | GKVFNNSSTLMKHKI CCCCCCCHHHHEEEE | 2.53 | 22798277 | |
271 | Phosphorylation | KVFNNSSTLMKHKII CCCCCCHHHHEEEEE | 2.75 | 22798277 | |
286 | Sumoylation | HTGKKPYKCEECGKA ECCCCCCCCHHHHHH | 9.82 | - | |
286 | Ubiquitination | HTGKKPYKCEECGKA ECCCCCCCCHHHHHH | 9.82 | - | |
286 | Sumoylation | HTGKKPYKCEECGKA ECCCCCCCCHHHHHH | 9.82 | - | |
308 | Phosphorylation | TRHKAIHTGEKPYKC HCCCCCCCCCCCCCC | 4.37 | 29496963 | |
311 | Sumoylation | KAIHTGEKPYKCEEC CCCCCCCCCCCCHHH | 2.94 | - | |
311 | Ubiquitination | KAIHTGEKPYKCEEC CCCCCCCCCCCCHHH | 2.94 | - | |
311 | Sumoylation | KAIHTGEKPYKCEEC CCCCCCCCCCCCHHH | 2.94 | - | |
313 | Phosphorylation | IHTGEKPYKCEECGK CCCCCCCCCCHHHHH | 63.41 | - | |
314 | Ubiquitination | HTGEKPYKCEECGKA CCCCCCCCCHHHHHH | 9.13 | - | |
314 | Sumoylation | HTGEKPYKCEECGKA CCCCCCCCCHHHHHH | 9.13 | - | |
314 | Sumoylation | HTGEKPYKCEECGKA CCCCCCCCCHHHHHH | 9.13 | - | |
342 | Sumoylation | HTGKKPYKCEECGKA ECCCCCCCCHHHHHC | 10.65 | - | |
342 | Ubiquitination | HTGKKPYKCEECGKA ECCCCCCCCHHHHHC | 10.65 | - | |
342 | Sumoylation | HTGKKPYKCEECGKA ECCCCCCCCHHHHHC | 10.65 | - | |
364 | Phosphorylation | RKHEIIHTEEKPYKY CCCCEEECCCCCCCH | 4.37 | - | |
367 | Sumoylation | EIIHTEEKPYKYEEC CEEECCCCCCCHHHH | 2.06 | - | |
367 | Sumoylation | EIIHTEEKPYKYEEC CEEECCCCCCCHHHH | 2.06 | - | |
398 | Sumoylation | HTGQKPYKCEECGKA ECCCCCEECCCCCCC | 9.13 | - | |
398 | Ubiquitination | HTGQKPYKCEECGKA ECCCCCEECCCCCCC | 9.13 | - | |
398 | Sumoylation | HTGQKPYKCEECGKA ECCCCCEECCCCCCC | 9.13 | - | |
476 | Phosphorylation | RKHEIIHTGEKPYKC HHCCEEECCCCCEEC | 4.37 | 29496963 | |
479 | Ubiquitination | EIIHTGEKPYKCEEC CEEECCCCCEECCCC | 2.94 | - | |
481 | Phosphorylation | IHTGEKPYKCEECGK EECCCCCEECCCCCC | 63.41 | - | |
482 | Sumoylation | HTGEKPYKCEECGKA ECCCCCEECCCCCCC | 11.36 | - | |
482 | Ubiquitination | HTGEKPYKCEECGKA ECCCCCEECCCCCCC | 11.36 | - | |
482 | Sumoylation | HTGEKPYKCEECGKA ECCCCCEECCCCCCC | 11.36 | - | |
497 | Phosphorylation | FKWSSKLTVHKVIHM CCCCCCCEEEEEECC | 40.71 | - | |
538 | Sumoylation | HTGKKPYKCEECGKA ECCCCCCCCHHHHHC | 8.46 | - | |
538 | Sumoylation | HTGKKPYKCEECGKA ECCCCCCCCHHHHHC | 8.46 | - | |
538 | Ubiquitination | HTGKKPYKCEECGKA ECCCCCCCCHHHHHC | 8.46 | - | |
566 | Sumoylation | HTGKKPYKCEECGKA ECCCCCCCCHHHHHH | 9.13 | - | |
566 | Sumoylation | HTGKKPYKCEECGKA ECCCCCCCCHHHHHH | 9.13 | - | |
566 | Ubiquitination | HTGKKPYKCEECGKA ECCCCCCCCHHHHHH | 9.13 | - | |
587 | Ubiquitination | LTRHKAIHTGEKPYK HHCCCCCCCCCCCCC | 43.63 | - | |
588 | Phosphorylation | TRHKAIHTGEKPYKC HCCCCCCCCCCCCCC | 4.37 | 29496963 | |
591 | Sumoylation | KAIHTGEKPYKCEEC CCCCCCCCCCCCHHH | 2.94 | - | |
591 | Ubiquitination | KAIHTGEKPYKCEEC CCCCCCCCCCCCHHH | 2.94 | - | |
591 | Sumoylation | KAIHTGEKPYKCEEC CCCCCCCCCCCCHHH | 2.94 | - | |
593 | Phosphorylation | IHTGEKPYKCEECGK CCCCCCCCCCHHHHH | 62.56 | - | |
594 | Sumoylation | HTGEKPYKCEECGKA CCCCCCCCCHHHHHH | 8.85 | - | |
594 | Ubiquitination | HTGEKPYKCEECGKA CCCCCCCCCHHHHHH | 8.85 | - | |
594 | Sumoylation | HTGEKPYKCEECGKA CCCCCCCCCHHHHHH | 8.85 | - | |
622 | Sumoylation | HTGKKPYKCEECGKA ECCCCCCCCHHHHHC | 8.46 | - | |
622 | Ubiquitination | HTGKKPYKCEECGKA ECCCCCCCCHHHHHC | 8.46 | - | |
622 | Sumoylation | HTGKKPYKCEECGKA ECCCCCCCCHHHHHC | 8.46 | - | |
644 | Phosphorylation | RKHEIIHTGEKPYKC CCCCEEECCCCCEEC | 4.37 | 29496963 | |
647 | Ubiquitination | EIIHTGEKPYKCEEC CEEECCCCCEECCCC | 2.94 | - | |
649 | Phosphorylation | IHTGEKPYKCEECGK EECCCCCEECCCCCC | 63.41 | - | |
650 | Sumoylation | HTGEKPYKCEECGKA ECCCCCEECCCCCCC | 9.13 | - | |
650 | Ubiquitination | HTGEKPYKCEECGKA ECCCCCEECCCCCCC | 9.13 | - | |
650 | Sumoylation | HTGEKPYKCEECGKA ECCCCCEECCCCCCC | 9.13 | - | |
678 | Sumoylation | HTEEKPYKCEECGKA ECCCCCCCHHHHHHH | 12.19 | - | |
678 | Ubiquitination | HTEEKPYKCEECGKA ECCCCCCCHHHHHHH | 12.19 | - | |
678 | Sumoylation | HTEEKPYKCEECGKA ECCCCCCCHHHHHHH | 12.19 | - | |
706 | Ubiquitination | HTGKKPYKCEECGKA ECCCCCCCCHHHHHC | 9.55 | - | |
706 | Sumoylation | HTGKKPYKCEECGKA ECCCCCCCCHHHHHC | 9.55 | - | |
706 | Sumoylation | HTGKKPYKCEECGKA ECCCCCCCCHHHHHC | 9.55 | - | |
728 | Phosphorylation | RKHEIIHTGEKPYKC CCCCEEECCCCCEEC | 3.96 | 29496963 | |
731 | Ubiquitination | EIIHTGEKPYKCEEC CEEECCCCCEECCCC | 1.70 | - | |
733 | Phosphorylation | IHTGEKPYKCEECGK EECCCCCEECCCCCC | 13.01 | - | |
734 | Sumoylation | HTGEKPYKCEECGKA ECCCCCEECCCCCCC | 21.54 | - | |
734 | Ubiquitination | HTGEKPYKCEECGKA ECCCCCEECCCCCCC | 21.54 | - | |
734 | Sumoylation | HTGEKPYKCEECGKA ECCCCCEECCCCCCC | 21.54 | - | |
790 | Ubiquitination | HTGKKPYKCEECGKA ECCCCCCCCHHHHHC | 25.88 | - | |
790 | Sumoylation | HTGKKPYKCEECGKA ECCCCCCCCHHHHHC | 25.88 | - | |
790 | Sumoylation | HTGKKPYKCEECGKA ECCCCCCCCHHHHHC | 25.88 | - | |
812 | Phosphorylation | RKHEIIHTGEKSYKC CCCEEEECCCCEEEC | 52.94 | 27251275 | |
815 | Ubiquitination | EIIHTGEKSYKCEEC EEEECCCCEEECCHH | 39.62 | - | |
818 | Sumoylation | HTGEKSYKCEECGKA ECCCCEEECCHHHHH | 53.58 | - | |
818 | Sumoylation | HTGEKSYKCEECGKA ECCCCEEECCHHHHH | 53.58 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZNF99_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZNF99_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZNF99_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of ZNF99_HUMAN !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...